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ABSTRACT OF THE THESIS 
 
General Fatalism and Diabetes Fatalism as Predictors of Diabetes Treatment Adherence 
 
by 
Esmeralda Ibette Nuñez 
Doctor of Philosophy, Graduate Program in Psychology 
Loma Linda University, June 2016 
Dr. Hector M. Betancourt, Chairperson 
 
 Greater conceptual distinction between fatalism as a cultural value orientation 
(general fatalism) and disease-specific fatalism is necessary to evaluate fatalism as a 
predictor of health behaviors such as diabetes treatment adherence. We tested an 
integrated, theory-driven structural model of relationships among income, education, age, 
gender, general fatalism, diabetes fatalism, and type 2 diabetes treatment adherence, as 
measured by hemoglobin a1c levels (hba1c), in a sample of mainstream-Chileans (n=229) 
and indigenous people of Chile known as the Mapuche (n=134). Hypotheses were that 
higher income and education would predict more general fatalism and diabetes fatalism 
across ethnic groups and higher general fatalism would indirectly predict higher hba1c 
through diabetes fatalism. Multi-group structural equation modeling comparing ethnic 
groups revealed excellent fit of models (Mapuche: CFI = .995, χ2 (24, n = 229) = 27.26, p 
=.29, χ2/df = 1.14, RMSEA = .024, 90% CI (.000, .061), R2= 0.148; mainstream-Chilean: 
CFI = 1.000, χ2 (24, n = 134) = 22.15, p =.57, χ2/df = .92, RMSEA = .000, 90% CI (.000, 
.064), R2=0.043) and partial supported of study hypotheses. Fewer years of education 
significantly predicted general fatalism and lower income significantly predicted diabetes 
fatalism across ethnic groups. Higher general fatalism was a significant indirect predictor 
of hba1c through diabetes fatalism only for mainstream-Chileans. This study highlights 
 x 
the importance of measuring fatalism as a cultural value and disease-specific fatalism as 
antecedents of health behavior. Findings also underscore the necessity of studying how 
social structural factors influence health behavior through culture and disease-specific 
beliefs.  
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CHAPTER ONE 
INTRODUCTION 
 
 Fatalism has been conceptualized as a cultural value orientation (general fatalism) 
that reflects a social group’s general understanding of how humans should relate to nature 
and whether people should try to control events in their environment or be subjugate to 
them (Kluckhohn & Strodtbeck, 1961). Contrastingly, disease-specific fatalistic beliefs 
are beliefs that death is inevitable when a disease is present, that some health outcomes 
are outside human control and are predetermined, and that health outcomes are controlled 
by external forces, powerful others, or chance (Egede & Bonadonna, 2003; Powe et al., 
2003; Straughan & Seow, 1998). Researchers have described cancer-specific fatalism as 
stemming from the broader concept of fatalism, but more clarification is needed in terms 
of how general fatalism and disease-specific fatalism may differentially relate to health 
behaviors (Heiney, Gullatte, Hayne, Powe, & Habing, 2015).  
 
Fatalism and Ethnicity 
 Latinos have often been represented in the research literature as holding more 
fatalistic values than individuals of other ethnic groups.  In other words, Latinos have 
been understood as more likely to value a relationship between humans and nature in that 
humans do not try to control their environment. However, some investigators have noted 
the lack of evidence for the notion that Latinos are inherently more fatalistic than other 
ethnic groups and highlighted the assumption as a limitation of fatalism research 
(Abraído-Lanza et al., 2007). Powe and Finnie (2003), have explained that ethnic 
minority groups are high in cancer fatalism because of social circumstances of less 
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control with increased barriers to health that increase the odds of dying of cancer. 
Understanding social structural influences of disease-specific fatalism can help 
researchers better understand that certain ethnic minority groups are not inherently 
fatalistic, but may have more fatalistic health beliefs as a consequence of experiencing 
social circumstances of less control.  
  The connection between disease-specific fatalism and health behaviors among 
Latinos and other ethnic minorities is more consistently supported than the relationship 
between general fatalism and health behaviors. In a review of literature investigating the 
relevance of fatalism in the study of Latina’s cancer screening behavior Espinosa 
researchers found 11 quantitative studies that directly measured the relationship between 
fatalism and cancer screening behaviors in Latinas (Espinosa de los Monteros & Gallo, 
2011). Two of the 11 studies reviewed used a measure of general fatalism created by 
Cuéllar and authors as a predictor of cancer screening behavior (Cuéllar, Arnold, and 
González, 1995; Randolph, Freedman, & Freedman, 2002; Teran, Baezconde-Garbanati, 
Marquez, Castellanos, & Belkic, 2007). One study revealed that more general fatalism 
significantly predicted  less cancer screening behavior, while the other study found no 
relationship between general fatalism and cancer screening. Contrastingly, six out of the 
seven studies that measured disease-specific fatalism as a predictor of cancer screening 
found a statistically significant relationship such that higher levels of cancer fatalism 
predicted less cancer screening. In their discussion, the reviewers noted that “in regards 
to what would be most predictive of health behavior, it is not clear whether fatalism 
should be measured as a global trait or merely as a disease specific belief regarding the 
disease of interest” (p.316). 
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Fatalism and Diabetes Treatment Adherence  
 How general fatalism and disease-specific fatalism relate to treatment adherence 
in individuals with type 2 diabetes, the people of focus in the current research study, is 
unclear. In a review of culturally relevant issues among Hispanic individuals with 
diabetes, Caban and Walker (2006) emphasize the lack of consistency in how fatalism 
relates to diabetes self-management across studies.  The authors defined fatalism in more 
global terms, but included both studies that investigated general fatalism and diabetes 
fatalism in their review. Studies published subsequently to this review that assess fatalism 
and diabetes treatment adherence are few in number and generally use measures of 
diabetes fatalism rather than measures of general fatalism (Egede et al., 2003; Egede & 
Ellis, 2010; Osborn, Bains, & Egede, 2010; Walker et al., 2012). Researchers of one 
study found that diabetes fatalism directly predicted self-care behavior and indirectly 
predicted glycemic control as measured by hba1c blood levels (Osborn et al., 2010). In 
another study on the independent effects of diabetes fatalism on self-reported treatment 
adherence and self-care behaviors in type 2 diabetes, investigators reported that more 
diabetes fatalism significantly predicted less medication adherence, diet, exercise, and 
blood sugar testing (Walker et al., 2012).  
 
Sociostructural Determinants of Fatalism  
 As previously mentioned, investigators have emphasized sociostructural factors as 
significant determinants of disease-specific fatalism, such that lower socioeconomic 
status tends to predict higher levels of disease-specific fatalism. Other demographic 
factors, including age and gender, have been found to have an association with disease-
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specific fatalism though less consistently than income and education (Flynn, Betancourt, 
& Ormseth, 2011; Straughan et al., 1998). Studies discussing sociostructual predictors of 
general fatalism are also limited in number. Researchers of one study found that the 
relationship between Mexican identify and general fatalism was mediated by education, 
income, and occupational prestige (Ross, Mirowsky, & Cockerham, 1983). In the absence 
of guidance from multiple studies, researchers have suggested that multiple demographic 
factors must be carefully considered as potential sources of influence on culture values, 
health beliefs, and health behaviors (Betancourt & Flynn, 2009).  
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CHAPTER TWO 
THE PRESENT STUDY 
 The purpose of this study was to emphasize the conceptual distinction between 
general fatalism and disease-specific belief and to clarify how these two fatalism 
constructs are related to social structural factors and health behavior. More specifically, 
we examined how general fatalism and diabetes fatalism predicted diabetes treatment 
adherence in a sample of patients with type 2 diabetes. We used hba1c blood levels as a 
proxy variable for diabetes treatment adherence. In medical settings, the hba1c blood test 
is used as a biologic marker of whether a treatment plan is effective or to demonstrate the 
effect of medication, diet, and exercise choices (American Diabetes Association, 2014). 
In focusing on hba1c, Gonzalez and Schneider (2011) have note that information about 
specific patient behavior within the domains of medication, diet, and exercise adherence 
is lost. However, using a biologic marker of treatment adherence has the advantages of 
circumventing both the concern of bias in self-report measures and the uncertainty 
surrounding the validity of existent, commonly-used self-report adherence measures 
(Bennett Johnson, 1992; McNabb, 1997; Gonzalez et al., 2013).  
 The study sample is composed of mainstream-Chileans and the largest indigenous 
group in Chile known as the Mapuche. This sample is of particular interest for the study 
of fatalism and diabetes because the rate of diabetes mortality in Chile has been rising 
rapidly since the 1970s (Albala, Vio, Kain, & Uauy, 2001). The Mapuche, who at one 
point had the world’s lowest diabetes prevalence rate of under one percent, with 
increasing urbanization are now demonstrating rapid increases in the prevalence of 
diabetes (Carrasco et al., 2004; Pérez-Bravo et al., 2001). 
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 We argue that studying general fatalism as a disease–specific fatalism within an 
integrated framework is critical to understanding how social structural factors influence 
these cultural values and health beliefs, and in turn, how all these factors predict diabetes 
treatment adherence across ethnic groups. The proposed relationships among study 
variables were based on Betancourt’s model for the study of culture, psychological 
processes, and behavior adapted for the study of health behavior (see Figure 1; 
Betancourt et al., 2009). This is theory-driven, integrated model is useful in 
understanding how sociostructural, cultural, and psychological factors may influence 
health behaviors. Researchers have suggested that an integrative model is essential for the 
study of social and psychological determinants of health behavior (Gallo, Smith, & Cox, 
2006). A critical underlying principle of Betancourt’s model is that predictors of health 
behavior are structured from most distal to most proximal. Variables more proximal to 
behavior are theorized to have a greater impact on behavior. Another important aspect of 
the model is that culture may affect health behavior directly or indirectly through more 
proximal psychological processes, such as idiosyncratic beliefs and emotions that are 
experienced at the individual level. The most distal determinants of health behavior 
within this model are social categories such as socioeconomic status, ethnicity, age, and 
gender. These factors may not directly relate to health behavior but represent direct 
sources of cultural variation. A strength of Betancourt’s model is that it highlights the 
argument that ethnicity is not culture in and of itself, but instead is one of multiple 
sources of variation in culture. Considering multiple social structural factors as influences 
of culture may help researchers avoid inaccurate conceptions of ethnic minorities.  
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Figure 1. Betancourt’s Model of Culture and Behavior Adapted for Health Behavior 
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 Hypothesized relationships among general fatalism, diabetes-specific fatalism, 
and diabetes treatment behavior were also guided by attitude-behavior relations theory 
(zen & Fishbein, 1977; Ajzen & Fishbein, 2005). Researchers in this area have 
demonstrated that general cognitions (i.e., attitudes, values, beliefs) may inconsistently 
relate to specific behaviors but cognitions more specific to a behavior of interest tend to 
be more predictive of that behavior. This principle is exemplified by the inconsistency of 
the relationship between general fatalism and disease-specific health behaviors and the 
more consistent relationship between disease-specific fatalism and disease-specific health 
behaviors. Investigators have suggested that general cognitions can relate to specific 
health behaviors in certain circumstances, however this relationship can be missed if 
potential moderating/mediating variables are not considered. In the case of the 
relationship between general fatalism and diabetes treatment adherence, it is critical to 
consider the potential mediating effect of diabetes-specific fatalism. A measure of 
diabetes-fatalism is more likely to directly predict diabetes treatment adherence because 
it assesses beliefs that are specific to diabetes. We suggest that having general fatalism 
will relate to type 2 diabetes treatment adherence through diabetes fatalism. Although 
researchers have acknowledged disease-specific fatalism as stemming from the concept 
of fatalism more generally, to our knowledge no research group has examined the 
relationships among sociostructural factors, general fatalism, disease-specific fatalism in 
a single model.  
 The hypothesized relationships in this study were tested through the structural 
model presented in Figure 2. The demographic categories of education, income, gender, 
and age were tested as predictors of both general fatalism and diabetes fatalism based on 
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theory and previous research (Betancourt et al., 1993; Betancourt et al., 2009; Flynn et 
al., 2011; Powe et al., 2003; Straughan et al., 1998). Additionally, we tested diabetes 
fatalism as a direct predictor of hba1c blood levels. General fatalism was tested as both a 
direct predictor and indirect predictor of type 2 diabetes treatment adherence through 
diabetes fatalism. However, we hypothesized that higher cultural fatalism would 
indirectly relate to health behavior through disease-specific fatalism. Specific study 
hypotheses were as follows: 
1. Income and education will directly predict general fatalism and diabetes fatalism 
in both mainstream-Chilean and Mapuche participants such that lower income and 
fewer years of education will predict higher levels of general fatalism and 
diabetes fatalism.  
2. Diabetes fatalism will directly predict type 2 diabetes treatment adherence in both 
mainstream-Chilean and Mapuche participants such that higher levels of diabetes 
fatalism will predict higher/worse hba1c blood levels. General fatalism will 
indirectly predict hba1c blood levels through diabetes fatalism in both mainstream 
Chiliean and Mapuche participants such that higher levels of general fatalism will 
predict higher levels of diabetes fatalism, which will, in turn, predict higher hba1c 
blood levels. 
  
1
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Proposed Structural Model of Relationships. Separate models will be run for mainstream-Chilean and Mapuche participants 
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Method 
Participants 
 As part of a larger research program investigating cultural and psychological 
factors relevant to diabetes management, multi-stage stratified sampling was used to 
obtain participants from demographic backgrounds conceived as sources of cultural 
variation from both public and private health clinics in the Araucanía region of Chile. A 
total of 394 type 2 diabetics were recruited (Mapuche; n = 146, mainstream-Chilean; n = 
254). Potential participants were contacted by phone with the support of clinic directors 
to explain the purpose of the study, Inclusion criteria were being 18 years of age, having 
a diagnosis of diabetes for over one year, and being non-insulin dependent.  
 
Materials 
Ethnicity 
 Ethnicity was self-reported by participants as either Mapuche or mainstream-
Chilean and used as a moderating variable in multi-group analyses.  
 
Sociostructural Sources of Cultural Variation 
 Income, education, age, and gender were included in structural equation model as 
social structural sources of cultural variation. Participants indicated their age in years, 
number of years of education, and annual household income based on six categories (see 
Table 1). The variable for gender was dummy coded with females coded as 0 and males 
coded as 1. 
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General Fatalism 
 General fatalism was measured with Betancourt’s Fatalism Scale based on the 
work of cultural anthropologists Kluckhohn and Strodtbeck (1961). It consists of 10-
items rated on a 7-point scale with ratings ranging from strongly disagree to strongly 
agree. The scale represents items designed to assess fatalistic value orientation. Higher 
scores on the scale represent stronger fatalistic values. See Appendix A for Betancourt’s 
Fatalism Scale. Confirmatory factor analysis revealed that all the items loaded on one 
factor of general fatalism.  The scale was found to be highly reliable across ethnicity 
(mainstream-Chilean α = 0.85, Mapuche α = 0.84).  
 
Diabetes Fatalism  
 Diabetes fatalism was measured using the 6-item Diabetes Fatalism Scale. The 
scale was developed with Mapuche and mainstream-Chilean type 2 diabetes patients 
based on the bottom-up mixed methods cultural research approach to instrument 
development (see Betancourt, Flynn, Riggs, & Garberoglio, 2010). This method begins 
with observations with members of the population of interest (e.g. Mapuche and 
mainstream-Chilean patients), which are derived through interviews. Based on the 
interview responses, close-ended items are developed and compiled into a quantitative 
scale. The resulting scale represents items designed to assess fatalistic beliefs about 
diabetes. Higher scores on the scales represent higher levels of diabetes-specific fatalistic 
beliefs. Confirmatory factor analysis revealed that the items loaded onto one factor. The 
scale demonstrated adequate reliable across ethnic groups (mainstream-Chilean α = 0.71, 
Mapuche α = 0.72). See Appendix A for Diabetes Fatalism Scale.  
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Diabetes Treatment Adherence 
 Hba1c blood percentage was used as a biological index of diabetes treatment 
adherence. The measure is obtained using a sample of blood and indicates an individuals’ 
average blood glucose (blood sugar) control for the past 2 to 3 months. Hba1c is used as 
an indicator of whether a treatment plan is effective or to demonstrate the effect of 
medication, diet, and exercise choices. Values range from about 5% to 14%. Individuals 
without diabetes normally have an hba1c range from 4.5 to 6%. Diabetes is usually 
diagnosed at 6.5% or higher. Diabetes treatments usually aim to maintain an hba1c level 
of 7%. Higher hba1c blood levels suggest lower diabetes treatment adherence and more 
risk for diabetes complications (American Diabetes Association, 2014).   
 
Covariates 
 This study relied primarily on participant self-report. As such, social desirability, 
as measured by the 13-item Marlowe-Crowne Social Desirability Scale, was assessed as a 
covariate (Crowne & Marlowe, 1960). 
 
Procedure 
 Individuals were recruited between September 2011 and February 2012 through 
private and public health centers in Temuco, Chile and rural areas of the region. 
Healthcare personnel assisted in recruitment as well as flyers posted and distributed in 
public and private healthcare facilities. Potential participants were contacted by phone 
with the support of clinic directors to explain the purpose of the study, including the 
inclusion/exclusion criteria. Those interested in participation contacted the research office 
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and were further screened for eligibility. They were informed that participation would 
involve 30-45 minute questionnaire and a free hba1c blood test. They would be 
compensated 5,000 pesos ($10 U.S.) for their time. Those who met inclusion criteria 
were scheduled for participation at a research facility at the Universidad de la Frontera, 
School of Medicine. Those who lived in rural areas reported to an office space provided 
at a local health clinic.  
 Once at the research facility, in 4-6 participants per sessions, participants were 
again read the purpose of the study and guided through informed consent. Once written 
consent was obtained, participants were given the questionnaire. Participants were 
surveyed about a variety of diabetes-related beliefs and behaviors as well as some 
experiences within the Chilean healthcare system. All participants were encouraged to 
ask questions. If a participant was unable to read, a research assistant guided the 
individual through the questionnaire in a private setting. Upon completing the 
questionnaire, participants were then given an hba1c blood test and their heights and 
weights were measured. Finally, participants were given the results of their hba1c test, 
debriefed, and paid. 
 This study was funded by CONICYT (National Commission for Scientific and 
Technological Research, Government of Chile; FONDECYT Project #1090660 to Dr. H. 
Betancourt, P.I.), and approval for the study was obtained from the public university 
ethics committee for research and the regional office of the Chilean Ministry of Health 
(SEREMI de Salud, Region de La Araucanía). 
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Statistical Analyses 
 Before testing the study hypotheses, data were screened for missing data, 
multivariate outliers, and assumptions for multivariate normality (Kline, 2011). 
Confirmatory factor analyses (CFA) using Bentler’s (2006) structural equation modeling 
were performed for Betancourt’s Fatalism Scale and Diabetes Fatalism Scale and verified 
that these scales factored into single-independent, though correlated factors.  
 In order to test the strength of relationships among study variables across ethnic 
groups, the study hypotheses were tested using Bentler’s multi-group structural equation 
modeling with Bentler’s (2006) structural equations program (EQS), maximum 
likelihood method of estimation. Based on theory and previous research, we reasoned that 
ethnicity in and of itself would not be a significant predictor of general fatalism nor 
diabetes-fatalism. We tested separate, but identical structural equation models for 
mainstream-Chilean and Mapuche participants in order to establish structural invariance. 
Income, education, age, and gender were included in the tests of models as social 
structural sources of cultural variation. Fit were accessed using non-significant χ2 
goodness-of-fit statistic, a ratio of less than 2.0 for the χ2/df  ratio (Tabachnick & Fiddell, 
2007), a Comparative Fit Index (CFI) of .95 or greater, Root Mean Square Error of 
Approximation (RMSEA) of less than .08 (Browne & Cudeck, 1993), and RMSEA 
upper-bound  confidence interval below .10 (Kline, 2011). Modifications of the 
hypothesized models were performed based on results from the Lagrange multiplier (LM) 
test and the Wald test in combination theory and research.   
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CHAPTER THREE 
RESULTS  
Preliminary Analyses 
 The final analyses included 229 mainstream-Chilean and 134 Mapuche type 2 
diabetes patients. Thirty-one participants were missing data on one or more of the items 
from noted multi-item scales or key covariates such as the gender of the health 
professional and were eliminated from subsequent analysis. Less than 5% of cases were 
missing data for any single variable, which Kline (2011) notes is of little concern in a 
large sample especially if pattern of missingness is nonsystematic. A missing value 
analysis and a Little’s Missing Completely at Random test did not indicate statistical 
deviation from randomness for the sample (p=0.241).  There were no statistically 
significant differences between the omitted and retained sample in terms of ethnicity, 
gender, age, income, education, and hba1c blood levels.  
  Table 1 presents demographic information of final sample. Overall, Mainstream-
Chilean participants reported significantly more years of education (t(359) = -10.08, p < 
.001)and yearly household income (t(359) = -8.22, p < .001) than Mapuche participants . 
Mainstream-Chilean participants had a significantly lower Body Mass Index (BMI) than 
Mapuche participants (t(359) = 2.44, p < .05), but the groups did not differ significantly 
in terms of hba1c blood glucose levels. The percentage of male and female participants 
was significantly different between ethnicities (c2(1, N = 363) = 7.59, p < .01).  
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Table 1. Final sample demographics based on ethnicity.  
 
Variable Mapuche (n =134) Mainstream-Chilean (n =229) 
Age 58.84(13.06) 57.32(13.82) 
Education* 5.41(4.37) 10.12 (4.23) 
BMI* 32.44(6.44) 30.87(5.44) 
Hba1c 7.46(2.24) 7.08 (1.83) 
Income* n(%) n(%) 
0-150 108(80.60) 94(41.00) 
151-250 13(9.70) 59(25.80) 
251-500 12(9.00) 53(23.10) 
501-1000 1(0.70) 20(8.70) 
1000-1500 0(0.00) 1(0.40) 
above 1500 0(0.00) 2(0.90) 
Gender* 95(70.90) 129(56.30) 
 
Note. *p <. 05 
 
 Table 2 includes the means and standard deviations for the study variables. The 
table also includes the correlations among the study variables.  Fischer’s r-to-z test of 
difference demonstrated two significantly different bivariate correlations based on 
ethnicity, confirming the need to conduct a test of invariance. The correlation between 
age and hba1c were significantly different across ethnicities (z= -2.41, p < .05). 
Additionally, the correlation between gender and Parcel 2 of the diabetes fatalism 
measure were significantly different across ethnicities (z= -2.40, p < .05). 
 As previously mentioned, social desirability was examined as a potential 
covariate prior to using structural equation modeling. Social desirability did not 
significantly covary with any other study variable. 
  
1
8
 
 
Table 2.  Intercorrelations, means, and standard deviations as a function of ethnicity 
 
Study Variable 1 2 3 4 5 6 7 8 9 10 
1. Age -          
 -          
2. Gender 0.136 -         
 (0.226**) -         
3. Education -.556** 0.109 -        
 (-0.260**) (0.122) -        
4. Income -0.169 0.209* 0.569** -       
 (-0.151*) (0.193**) (0.523**) -       
5. General Fatalism 
Parcel 1 
0.039 -0.087 -0.234** -0.246** -      
 (0.118) (-0.084) (-0.298**) (-0.180**) -      
6. General Fatalism 
Parcel 2 
0.118 -0.093 -0.383** -0.318** 0.654** -     
 (0.175**) (-0.068) (-0.428) (-0.225**) (0.740**) -     
7. Diabetes 
Fatalism Parcel 1 
0.171* -0.028 -0.258** -0.180* 0.223** 0.263** -    
 (0.148) (0.039) (-0.320**) (-0.216**) (0.361**) (0.422**) -    
8. Diabetes 
Fatalism Parcel 2 
0.087 -0.194* -0.218** -0.290** 0.187* 0.257** (0.488**) -   
 (0.067) (0.067) (-0.289**) (-0.245**) (0.344**) (0.403**) 0.528** -   
9. Diabetes 
Fatalism Parcel 3 
0.155 -0.071 -0.312** -0.344** 0.148 0.383** (0.536**) 0.509** -  
 (0.130*) (-0.008) (-0.363) (-0.266**) (0.228**) (0.410**) 0.084 (0.567**) -  
10. Hba1c -0.296** 0.036 0.067 -0.074 0.124 0.158 (0.126) 0.143 0.097 - 
 (-0.041) (0.092) (-0.113) (-0.074) (-0.03) (-0.025) 5.31 (0.093) (0.087) - 
M 58.84 - 5.41 1.30 5.97 5.62 5.31 4.67 5.16 7.46 
 (57.32) - (10.12) (2.05) (5.33) (4.77) (4.28) (4.12) (4.27) (7.08) 
SD 13.06 - 4.37 0.66 1.21 1.51 1.83 2.05 1.80 2.24 
 (13.82) - (4.23) (1.08) (1.34) (1.70) (1.77) (1.94) (1.96) (1.83) 
 
Note. Correlations, means, and standard deviations for mainstream-Chilean participants (n = 229) are listed in parentheses below those for Mapuche participants 
(n = 134). Boldface indicates that the groups differ significantly at p < .05. *p < .05 level (2-tailed); **p < .01 level (2-tailed) 
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Structural Equation Modeling 
 Before conducting multi-group structural equation modeling, data screening 
revealed a violation of multivariate normality for both ethnic groups. Consequently, we 
used a corrected normal theory method of analysis with original data and reported ML 
robust test statistics, corrected model statistics that are robust against non-normality 
(Kline, 2011). The tested model demonstrated good fit for mainstream-Chilean 
participants, but poorer fit for Mapuche participants (mainstream-Chilean: CFI = 0.997, 
χ2 (23, n = 229) = 24.97, p = 0.35 χ2/df = 1.08, RMSEA = .019, 90% CI (.000, .059), R2= 
0.041; Mapuche: CFI = 0.951, χ2 (23, n = 134) = 37.78, p = 0.03 χ2/df = 1.64, RMSEA = 
.069, 90% CI (.023, .107), R2= 0.029). Based on the Lagrange test, theory, research, 
logic, structural paths from age to diabetes fatalism and gender to general fatalism were 
dropped from the models for both groups. Based on the Wald test and theory suggesting 
that in some instances population factors may relate directly to health behavior, a direct 
path was added from age to hba1c. The resulting model is presented in Figure 3. The 
model for fit the data well for mainstream-Chilean participants (CFI = .995, χ2 (24, n = 
229) = 27.26, p =.29, χ2/df = 1.14, RMSEA = .024, 90% CI (.000, .061), R2= 0.043). The 
model also fit the data well for Mapuche participants (CFI = 1.000, χ2 (24, n = 134) = 
22.15, p =.57, χ2/df = .92, RMSEA = .000, 90% CI (.000, .064), R2= 0.148). 
  
2
0
 
 
Figure 3. Final Structural Model of Relationships. Mapuche: CFI = 1.000, χ2 (24, n = 134) = 22.15, p =.57, χ2/df = .92, RMSEA = 
.000, 90% CI (.000, .064), R2= 0.148; mainstream-Chilean; CFI = .995, χ2 (24, n = 229) = 27.26, p =.29, χ2/df = 1.14, RMSEA = .024, 
90% CI (.000, .061), R2= 0.04. 
Diabetes 
Fatalism 
General 
Fatalism 
Parcel 1 Parcel 2 
HbA1c 
Parcel 2 Parcel 1 
Age 
Income 
Educatio
n 
Gender 
Parcel 3 
-0.34*** 
0.32** 
(-0.06) 
(0.45)*** 
 
 
 
 
 
0.11 
(0.12†) 
-0.17† 
(-0.15*) 
0.57* 
(0.52***) 
-0.56*** 
(-0.26***) 
0.21* 
(0.19**
) 
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Test of Research Hypotheses 
  The first hypothesis concerning the direct effects of income and education on 
general fatalism and diabetes fatalism was partially supported. For both Mainstream-
Chilean and Mapuche participants only years of education significantly predicted general 
fatalism (Mainstream-Chilean β = -0.41; Mapuche β = -0.37). This relationship was in the 
hypothesized direction, with less years of education predicting more general fatalism. 
Lower income and less years of education significantly predicted more diabetes fatalism 
only for Mainstream-Chilean participants (Income β = -0.16; Education β = -0.19). 
 The second hypothesis that diabetes fatalism would directly predict diabetes 
treatment 
 adherence was partially supported. Higher diabetes fatalism significantly predicted 
higher hba1c for Mainstream- Chilean participants (β = 0.25). Diabetes fatalism did not 
significantly predict hba1c for Mapuche participants, however, the relationship between 
diabetes fatalism and hba1c was in the expected direction and was trending toward 
significance (β = 0.16, p<.10).  
 The third hypothesis that higher levels of general fatalism would indirectly predict 
lower diabetes treatment adherence through higher levels of diabetes fatalism was also 
partially supported. For both Mainstream-Chilean and Mapuche participants higher levels 
of general fatalism significantly predicted higher levels of diabetes fatalism (Mainstream-
Chilean β = 0.45 Mapuche β = 0.32). General fatalism had a significant indirect effect on 
hba1c through diabetes fatalism for Mainstream-Chilean participants (indirect β = 0.11, p 
<.05).  
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Test of Structural Invariance 
 Because preliminary analyses revealed that ethnicity moderated the correlations 
between age and hba1c, a test of structural invariance was conducted. Review of the LM 
test of equality constraints statistics revealed significant between-group differences in 
the path from age to hba1c. The magnitude of this effect was stronger for Mapuche 
participants as compared to mainstream-Chilean participants. Once the path constraint 
from age to hba1c was released the fit demonstrated by the resulting model improved. 
The fit of this model was once again comparable to the configural model, suggesting 
that no other paths should be released (see Table 3).   
 
Table 3. Model summary for tests of configural, measurement, and structural invariance 
across ethnicity 
 
Model S-BΧ2 df CFI RMSEA(90% CI) ΔS-BΧ2a p Δdf ΔCFI 
 
Configural 
Invariance 
 
 
47.291 
 
48 
 
1 
 
0(0.000,0.047) 
 
- 
 
- 
 
- 
 
- 
Measurement 
Invariance 
 
47.933 51 1 0(0.000,0,043) 0.493756949 0.92 3 0 
Structural 
Invariance  
 
70.789 61 0.989 0.03(0.000,0.056) 24.32047234 0.023 13 -0.011 
Partial Structural 
Invariance  
62.706 60 0.997 0.016(0.000,0.049) 15.64723554 0.208 12 -0.003 
 
Note. Configural invariance model has no constraints; measurement invariance model 
factor loadings constrained across ethnicities; structural invariance model constrained 
factor loadings and 10 structural paths; partial structural invariance model constrained 
factor loadings and 9 structural paths, released path from ‘Age’ to ‘Hba1c’. 
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CHAPTER FOUR 
DISCUSSION 
 The results of this study provide clarification regarding two conceptual issues 
within fatalism research and further the study of fatalism in relation to type 2 diabetes 
treatment adherence. The first of these issues is the lack of conceptual differentiation in 
the research literature between measures of fatalism as a global, cultural value orientation 
and fatalism as a disease-specific belief. In the current study, higher levels of diabetes 
fatalism significantly predicted higher hba1c blood levels for Mainstream-Chilean 
participants. Though this relationship was not statistically significant for Mapuche 
participants, it was in the anticipated direction and trended toward significance. General 
fatalism did not have a significant direct effect on diabetes treatment adherence, but 
instead related to hba1c through more specific fatalistic beliefs about diabetes. This 
finding is in accordance with the relationship between suggested among these variables 
by Betancourt’s model  and  attitude-behavior principles.  General cognitions may 
inconsistently predict specific behaviors because the relationships among general 
cognitions and specific behaviors are often mediated/moderated by cognitions that are 
more specific to that behavior. To our knowledge, no publication to date has assessed 
these constructs simultaneously in relation to diabetes treatment adherence. Furthermore, 
no previous study to our knowledge has proposed a framework for how general fatalism 
and disease-specific fatalism both relate to health behavior. 
 This study highlights the importance of making the conceptual distinction 
between general fatalism and diabetes fatalism and measuring both constructs in relation 
to health behaviors. General fatalism was not a significant direct predictor of hba1c in 
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this study. Had our model only included a measure of general fatalism, it may have 
seemed that general fatalism does not relate to diabetes treatment adherence. However, 
including general fatalism and diabetes fatalism in our study revealed how diabetes 
fatalism directly and significantly predicted specific fatalistic beliefs about diabetes 
across ethnicities, while general fatalism indirectly predicted hba1c through diabetes 
fatalism for mainstream-Chilean participants.  
 Another critical reason for differentiating general fatalism and diabetes fatalism is 
for the purpose of better understanding the social structural determinants of general 
fatalism and diabetes fatalism. In the current study, fewer years of education significantly 
predicted more general fatalism across ethnic groups. Similarly, lower income 
significantly predicted more diabetes fatalism across ethnicities. These findings lend 
support to researchers who have argued that fatalism is related to social circumstances of 
less control rather than ethnicity in and of itself.  
 Several unexpected and significant relationships arose in this investigation and 
warrant further investigation. That age had a significant negative association with lower 
hba1c for Mapuche participants was one such unexpected result. Possible explanations of 
this finding are that older Mapuche participants may adhere more to their diabetes 
treatment or that younger Mapuche participants tend to have a lifestyle more similar to 
that of mainstream-Chileans because of trends toward urbanization. These findings 
highlight the complexity of the relationships among social structural factors, culture, 
health beliefs, and health behavior. Additionally, these findings point to the need to 
consider a broad range of social structural factors and demographic categories, beyond 
ethnicity, that can uniquely affect the culture and health beliefs of different social groups.  
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 An additional query that this study brings forward is the question of why diabetes 
fatalism significantly predicted hba1c blood levels for Mainstream-Chilean participants 
but not for Mapuche participants. In the present study, we did not make any a priori 
hypotheses about psychological variables because of the primacy of making the 
conceptual distinction between general fatalism and disease-specific fatalism and testing 
how general fatalism and disease-specific fatalism relate to health behavior. However, 
Betancourt’s model highlights the importance of psychological factors as direct 
predictors of health behavior and as potential mediators between cultural factors and 
health behavior.  Flynn and authors (2011) found that cancer screening fatalism was a 
significant indirect predict of clinical breast exam adherence through the psychological 
factor of emotions for Latino women but not Anglo women.  Researchers have also 
shown demonstrated that self-efficacy, defined as an individual’s belief in his/her 
capacity to execute behavioral change that reflects confidence in his/her ability control 
personal motivation, behavior, and the social environment, is a critical psychological 
predictor of a variety of health behavior including diabetes self-management (Abubakari, 
Cousins, Thomas, Sharma, & Naderali, 2015; Bandura, 2004). Future researchers should 
investigate emotions related to diabetes fatalism, self-efficacy, and other psychological 
factors as potential mediators of the relationship between diabetes fatalism and diabetes 
adherence.  
 Limitations of this research include reliance on hba1c as a proxy for diabetes 
adherence. Using a biological indicator of adherence has the advantage of not being 
subject to the biases of self-report measures, however, hba1c is influenced by other 
genetic and physiological factors besides behavioral compliance. In using hba1c, we are 
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unable to report how general fatalism and diabetes fatalism relate to specific aspects of 
adherence such as engaging in medication, eating, and exercise behaviors recommended 
for individuals with type 2 diabetes. In a post-hoc analysis, general fatalism and diabetes 
fatalism generally had no significant correlation with self-reported diabetes adherence in 
the domains of medication, exercise, and diet as measured by the Summary of Diabetes 
Self-Care Activities (SDSCA) across mainstream-Chilean and Mapuche participants. 
Similarly, the correlations between self-reported type 2 diabetes treatment adherence and 
hba1c were generally nonsignificant.  These correlations could not attributed to the effect 
of social desirability.  However, one possible explanation for this inconsistency goes back 
to attitude-behavior theory. The SDSCA anchors individuals to answer questions based 
on the past 7 days of adherence behavior, thus violating measurement compatibility when 
relating the SDSCA with diabetes fatalism, which has no time anchor, and hba1c, which 
is a general biological marker of 3-month adherence. The SDSCA, though often used, has 
related inconsistently to other diabetes adherence measures across studies (Gonzalez et 
al., 2011).  
 In the future, researchers should consider looking at how sociostructural factors, 
general fatalism, and diabetes fatalism relate to behavioral measures of diabetes 
adherence and hba1c across time. It is important to note that our data were collected in a 
cross-sectional design. Longitudinal data would provide stronger evidence for the causal 
relationships proposed among sociostructural factors, general fatalism, diabetes fatalism, 
and type 2 diabetes treatment adherence.  In addition to studying these relationships in a 
longitudinal study, researchers interested in how fatalism relates to behavior across 
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different social groups should further investigate fatalism in relation to such social 
categories as gender and age.   
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APPENDICES 
APPENDIX A 
General Fatalism Scale  (1 to 7 Likert scale) 
Parcel 1 (Unpredictability) 
1. The future appears to be totally unpredictable 
2. When things begin to happen in life that you want, something happens and things 
change 
3. Life is so uncertain that it’s best to take things day by day 
4. There are so many ups and downs in life that you can’t know what will happen in the 
end  
5. There are so many things that can happen that it’s difficult to plan for the future  
 
Parcel 2 (Predestination) 
1. In real life there is little that you can do to change things  
2.Success depends on destiny, like being in the right place at the right time 
3. Something that is going to happen will happen, no matter what you do 
4. Destiny determines how successful one will be in life, therefore there is not much 
else you can do about it  
5. Each person has a set time to live, and when that time is over, it’s over 
 
Diabetes Fatalism Scale  (1 to 7 Likert scale) 
When the diabetic DOES NOT follow treatment it is because:  
 
Parcel 1 
1. Diabetes leads to death and there is not much that can be done about it  
2. You think that everybody dies from something, and if it is not from diabetes, it will be 
from something else. 
Parcel 2  
1. When you follow your diet you do not feel different 
2. If you are destined to have diabetes, then you will suffer no matter what 
Parcel 3 
1. You believe that no matter what you do, you are not going to get better 
2. In the end, what happens with diabetes is in the hands of God  
 
Self-Reported Adherence 
Diet: On average, during the last month, how many days per week did you follow your 
diet? 
 
Exercise: How many of those seven days did you do at least 30 minutes of continuous 
exercise? (including walking) 
 
Medication: On how many of those days did you take your prescribed drugs for 
diabetes? 
 
